Source: International Congress 2016 – Airway biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Adonis Protopapas (Thessaloniki, Greece), Adonis Protopapas, Stergios Vradelis, Theodoros Karampitsakos, Athanasios Chatzimichail, Emmanouil Paraskakis. Elevated levels of alveolar nitric oxide in patients with inflammatory bowel disease. Eur Respir J 2016; 48: Suppl. 60, 1065

Member's Comments

No comment yet.

Related content which might interest you: Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Exhaled nitric oxide levels in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients Source: Eur Respir J 2009; 34: 138-144 Year: 2009 Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis Source: Eur Respir J 2004; 24 : 609-614 Year: 2004 Increased alveolar concentrations of exhaled nitric oxide (NO) are associated with lung affection in systemic sclerosis (SSc) Source: Eur Respir J 2005; 26: Suppl. 49, 543s Year: 2005 Increased inflammation in peripheral airways of patients with systemic sclerosis, measured by fractional nitric oxide Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Airway and systemic nitric oxide pathway in COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Nitric oxide oxidation products in bronchoalveolar lavage of patients with different severity of asthma Source: Annual Congress 2013 –Asthma Year: 2013 Increased eNO and pulmonary iNOS expression in eNOS null mice Source: Eur Respir J 2003; 21: 770-773 Year: 2003 Changes in nitric oxide production in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006 Increased exhaled nitric oxide precedes lung fibrosis in a murine model of systemic sclerosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Alveolar nitric oxide is increased in uncontrolled asthma Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010